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ABSTRACT Patients with pain often display cognitive impairment including deficits in attention.
The visual-signal detection task (VSDT) is a behavioral procedure for assessment of attention in rodents.
Male Sprague Dawley rats were trained in a VSDT and tested with three different noxious stimuli: (i)
intraperitoneal injection of lactic acid; (ii) intraplantar injection of formalin; and (iii) intraplantar injec-
tion of complete Freund’s adjuvant (CFA). The muscarinic acetylcholine receptor antagonist, scopola-
mine was also tested as a positive control. Scopolamine (0.01–1.0 mg/kg) dose dependently reduced
accuracy and increased response latencies during completed trials with higher scopolamine doses
increasing omissions. Lactic acid (0.56–5.6% ip) also increased response latencies and omissions,
although it failed to alter measures of response accuracy. Formalin produced a transient decrease in
accuracy while also increasing both response latency and omissions. CFA failed to alter VSDT perform-
ance. Although VSDT effects were transient for formalin and absent for CFA, both treatments produced
mechanical allodynia and paw edema for up to 7 days. These results support the potential for noxious
stimuli to produce a pain-related disruption of attention in rats. However, relatively strong noxious
stimulation appears necessary to disrupt performance in this version of the VSDT. Drug Dev Res 76 :
194–203, 2015. VC 2015 Wiley Periodicals, Inc.
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INTRODUCTION
The principal measures of pain in humans con-
sist of verbal reports structured by instruments such
as visual analog scales of pain severity [Melzack and
Katz, 2006]. However, noxious stimuli that elicit
verbal reports of pain in humans also produce
changes in nonverbal behavior in both humans and
animals, and these nonverbal pain-related behaviors
serve both as clinically relevant endpoints in pain
assessment and as dependent measures in preclinical
pain research [Negus et al., 2006; Mogil, 2009;
Whiteside et al., 2013]. One category of pain-related
changes in behavior is impairment of cognitive func-
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tion. Cognition embraces a range of processes that
include attention, perception, working memory, long-
term memory, executive function, language, and
social cognition [Keeler and Robbins, 2011], and pain
has the potential to commandeer finite cognitive
resources and reduce their availability for processing
other stimuli. For example, chronic pain reduces
measures of attention in humans [Eccleston, 1994;
Crombez et al., 1997; Lorenz et al., 1997; Eccleston
and Crombez, 1999; Grace et al., 1999] and rodents
[Boyette-Davis et al., 2008; Pais-Vieira et al., 2009].
The visual-signal detection task (VSDT) is a
procedure used to assess attention in rats [Parasura-
man, 1984], and versions of the VSDT have been
used to study effects of various manipulations on
attention-related behavior [Bushnell et al., 1997;
Rezvani and Levin, 2004; Hillhouse and Prus, 2013].
The goal of this study was to assess changes in VSDT
performance of rats produced by three different pain
stimuli: (i) intraperitoneal injection of dilute lactic
acid; (ii) bilateral intraplantar injection of formalin;
and (iii) bilateral intraplantar injection of complete
Freund’s adjuvant (CFA).
Intraperitoneal injection of dilute acid is an
acute noxious stimulus that produces transient (1 h)
stimulation of a stretching response as well as tran-
sient depression of positively reinforced operant
responding in an assay of intracranial self-stimulation
(ICSS) [Pereira Do Carmo et al., 2009]. Intraplantar
formalin also stimulates robust expression of acute
pain behaviors (i.e., paw flinching and licking) for
approximately 1 h after administration, and these ini-
tial effects are followed by a more sustained (2
weeks) period of paw inflammation, necrosis, and
neuropathy accompanied by hypersensitive with-
drawal reflexes to thermal and mechanical stimuli
and depression of ICSS [Vierck et al., 2008; Grace
et al., 2014; Leitl et al., 2014]. Intraplantar CFA elic-
its fewer acute pain behaviors immediately after its
injection, but like formalin, it produces paw inflam-
mation and sustained thermal/mechanical hypersensi-
tivity, and it also produces significant but more
transient (1 day) depression of wheel running and
ICSS in rats [Vierck et al., 2008; Grace et al., 2014].
Thus, the noxious stimuli evaluated here differed in
the intensity of acute pain behaviors (acid5 forma-
lin>CFA) and the duration of more sustained signs
of pain such as mechanical hypersensitivity (formal-
in5CFA> acid). As a positive control, effects of
these noxious stimuli were compared with effects
produced by the muscarinic acetylcholine receptor
antagonist, scopolamine, which impairs attention in
humans [Lenz et al., 2012] and VSDT performance
in rats [Bushnell et al., 1997; Rezvani et al., 2009].
MATERIALS AND METHODS
Subjects
Seventeen adult, male Sprague-Dawley rats
(Harlan, Fredrick, MD, USA) were individually
housed and maintained on a 12-h light/dark cycle
with lights on from 6:00 a.m. to 6:00 p.m. All rats
were given restricted access to food to maintain 85%
of their ad libitum weights. Rats had free access to
water in their home cages. Animal maintenance and
research were in compliance with National Institutes
of Health guidelines on the care and use of animal
subjects in research. All animal use protocols were
approved by the Virginia Commonwealth University
Institutional Care and Use Committee.
Compounds
Scopolamine HCl (Sigma-Aldrich, St. Louis,
MO) was dissolved in saline for intraperitoneal (i.p.)
injection in a volume of 1 ml/kg, and doses are
expressed as the salt. Lactic acid (Spectrum Chemi-
cal, Gardena, CA) was diluted in bacteriostatic water
for i.p. injection in a volume of 1 ml/kg. Formalin
(Fisher Scientific, Waltham, MA; diluted in saline to
a 5% concentration) and CFA (Sigma-Aldrich) were
administered in 100-ll bilateral injections into the
plantar aspect of the left and right hind paws using a
27-g needle.
VSDT Apparatus
Experiments were conducted in six identical
operant chambers enclosed in sound attenuating cab-
inets equipped with a fan for ventilation and back-
ground noise (Med-Associates Inc., St. Albans. VT).
Each operant chamber was equipped with a round
signal light (2.5 cm in diameter), a houselight, two
retractable levers, and a food pellet dispenser. The
signal light was positioned in the center of the front
panel between the response levers and above the
food receptacle. Signal light intensity was adjusted
using a fader control that allowed for four different
illumination levels (i.e., background illumination and
three signal intensities; ENV-226A, Med-Associates
Inc.). Both background and signal illuminations were
calibrated using a light meter (LX1330B, HisGadget,
Union City, CA). Data were collected using Med PC
version 4.1 (Med-Associates Inc.).
Training
After initial lever-press training, rats were
trained according to procedures adapted from previ-
ously published studies [Bushnell, 1999; Rezvani and
Levin, 2004; Rezvani et al., 2009; Hillhouse and
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Prus, 2013]. Under the terminal schedule, daily ses-
sions consisted of 180 trials divided into a random-
ized sequence of 90 “blank” trials and 90 “signal”
trials. During blank trials, food was delivered only
after responding on one lever (the “blank” lever),
whereas during signal trials, food was delivered only
after responding on the other lever (the “signal”
lever). The assignment of left and right levers as the
blank and signal levers was counterbalanced across
rats. At the beginning of each trial, the levers were in
the retracted position, the house light was on, and
the signal light was illuminated at the low back-
ground intensity (0.6 lux). Each trial lasted 4.5–18.5 s
and began with a prestimulus delay of 3, 6, or 12 s
(30 blank trials and 30 signal trials with each delay,
presented in randomized sequence). Subsequently,
the “blank” or “signal” stimulus was delivered for
500 ms. During blank trials, there was no change in
intensity of the signal light. During signal trials, the
signal light intensity increased by 1.8 lux above back-
ground illumination. This stimulus was followed by a
1 s poststimulus delay, extension of the levers, and
initiation of a response period. The trial ended and
levers were retracted after a lever response was emit-
ted or after 5 s had elapsed, whichever occurred first.
If a correct response occurred during the response
period (i.e., response on the blank lever during a
blank trial or on the signal lever during a signal trial),
then lever retraction was accompanied by delivery of
a food pellet. Conversely, if an incorrect response
occurred, then lever retraction was accompanied by
initiation of a 2 s time out, during which both the
house light and signal light were turned off. Out-
comes of each trial were designated as follows: a cor-
rect response was designated as a “hit” during a
signal trial and a “correct rejection” during a blank
trial; an incorrect response was designated as a “miss”
on a signal trial and a “false alarm” on a blank trial;
and failure to emit a response within 5 s was consid-
ered an “omission.” Training was considered com-
plete when a rat responded correctly for at least 70%
of both blank and signal trials for 3 consecutive days.
Testing
Once training was complete, test sessions were
initiated. These were identical to the training ses-
sions, with the exception that signal intensity during
signal trials increased by one of three different values
(0.6, 1.2, or 1.8 lux) rather than only the highest
value of 1.8 lux. Thus, test sessions consisted of 90
blank trials and 30 trials for each of the three signal
intensities (equaling 90 total signal trials). Test ses-
sions were used to evaluate effects of four different
experimental manipulations. Scopolamine (0.01–
1.0 mg/kg i.p.) was tested as a positive control to con-
firm sensitivity of the procedure to effects of a mus-
carinic acetylcholine receptor antagonist as reported
in previous studies [Bushnell et al., 1997]. Subse-
quently, three different noxious stimuli were tested:
i.p. injection of dilute lactic acid (0.56–5.6% in dis-
tilled water and delivered in a volume of 1.0 ml/kg),
bilateral intraplantar injection of formalin (5% in
saline; 100 ll to each hind paw), or CFA (100 ll to
each hind paw). Scopolamine (20 min pretreatment)
was tested in a group of six experimentally na€ıve rats,
and lactic acid (0 min pretreatment) was tested in a
group of seven rats (six experimentally na€ıve, one
from scopolamine group). Test sessions for scopola-
mine occurred twice a week (typically Tuesdays and
Fridays) with at least 2 days separating each test,
whereas tests with lactic acid occurred only once a
week to minimize the potential for tissue damage
associated with closely spaced injections. A training
session was always conducted on the day immediately
preceding a test session, and the sequences of scopol-
amine and lactic acid doses were randomized across
rats in a Latin square design. Formalin was tested in
a group of five rats (one experimentally na€ıve and
four from scopolamine group). Data for the na€ıve rat
fell within the range of results obtained for the other
animals on most endpoints, including endpoints that
revealed significant effects, so text below reports
combined results for all five rats. CFA was tested in
a group of nine rats (four experimentally na€ıve and
five from i.p. acid group). The results of statistical
analyses were identical whether data from these two
groups were analyzed separately or together, so the
text below reports combined results for all nine rats.
In each group, rats were first treated with bilateral
intraplantar saline and tested 15 min later to deter-
mine vehicle effects. At least two days later, rats
were treated with bilateral formalin or CFA, and test-
ing was conducted 15 min, 3 days and 7 days after
treatment. The doses and pretreatment times for sco-
polamine were based on previous studies of scopola-
mine effects on performance of attention tasks in rats
[Milar, 1981; Bushnell et al., 1997; Rezvani et al.,
2009]. The doses and pretreatment times for lactic
acid, formalin, and CFA were based on previous
studies on pain-stimulated and pain-depressed behav-
ior [Pereira Do Carmo et al., 2009; Leitl et al.,
2014].
Paw Swelling and Mechanical Allodynia
Paw width and paw withdrawal threshold from
von Frey filaments were measured before and 7
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days after formalin or CFA treatment to provide
independent measures of inflammation-associated
swelling and mechanical allodynia after these treat-
ments. For paw width, dorsal-ventral thickness of the
left hind paw was measured to the nearest 0.01 mm
with electronic digital calipers (Traceable Calipers,
Friendswood, TX). The von Frey filament test was
used to measure sensitivity to a punctate pressure
stimulus. Rats were placed on an elevated mesh
galvanized steel platform in individual chambers with
a hinged lid and allowed to acclimate for at least
20 min. Subsequently, von Frey filaments (0.4–15 g
in approximate 0.25 log increments; North Coast
Medical, Morgan Hill, CA) were applied to the plan-
tar aspect of the left hind paw using the “up-down”
method to determine log median withdrawal thresh-
old [Chaplan et al., 1994]. Paw thickness and
mechanical sensitivity were assessed for each rat on
day 0 (before intraplantar formalin or CFA injection)
and day 7 (after the last test in the VSDT). Data for
paw width and mechanical allodynia before and after
formalin or CFA were compared by paired t-test, and
the criterion for significance was P< 0.05.
Statistical Analysis
The following dependent variables were used:
(i) percent hits for each signal intensity and for all
signal trials combined; (ii) percent correct rejections
for blank trials; (iii) response latency for signal and
blank trials; and (iv) response omissions for signal
and blank trials. Percent hits for each signal intensity,
and for all signal intensities combined, was calculated
as (number of correct responses on signal trials 4
number of signal trials completed) *100. Percent cor-
rect rejections was calculated as (number of correct
responses on blank trials 4 number of blank trials
completed) *100. Response latency for completed tri-
als was defined as the average time elapsed between
lever extension and occurrence of a response during
completed trials (determined separately for signal
and blank trials). Omissions were defined as total
number of trials during which no response occurred
(determined separately for signal and blank trials).
All data were reported as means6 the standard error
of the mean (SEM). Data were analyzed by one- or
two-factor repeated-measures analysis of variance
(ANOVA), and a significant ANOVA was followed by
a Dunnett’s or Newman–Keuls post hoc test depend-
ing on the desired comparison. The criterion for sig-
nificance was P< 0.05. All statistical analyses were
conducted using GraphPad Prism 6.0 for Windows
(La Jolla, CA).
RESULTS
Baseline Performance in the VSDT
To provide an overview of baseline performance
in the VSDT, Figure 1 shows performance during
signal trials after vehicle treatment for all 17 rats in
the study. There was a significant main effect of sig-
nal intensity [F(2,32)5 70.75, P< 0.0001]. Newman–
Keuls post hoc testing indicated that accuracy of per-
formance, quantified as percent hits, was intensity-
dependent such that accuracy increased with each
increase in signal intensity. When collapsed across all
signal intensities, mean6 SEM percent hit during
signal trials was 72.046 11.51, and the mean6 SEM
percent correct rejections during blank trials was
88.686 5.71. Average response latencies during sig-
nal and blank trials were 0.386 0.13 s and
0.426 0.13 s, respectively, and the average numbers
of response omissions was 0.116 0.33 for both signal
and blank trials.
Effects of Scopolamine, Lactic Acid, Formalin,
and CFA on Response Accuracy
Figure 2 shows effects of scopolamine (0.01–
1.0 mg/kg) on accuracy of performance at each signal
Fig. 1. The effects of vehicle treatment on response accuracy dur-
ing signal trials. Abscissa: Change in signal light intensity in lux.
Ordinate: response accuracy quantified as percent hit. Statistically
significant effects of light intensity are noted. *P<0.05 versus 0.6
(lux); #P<0.05 versus 1.2 (lux) as determined by one-way ANOVA
followed by Newman–Keuls post hoc test. All data show mean-
6 SEM for 17 rats. Data are collapsed across all types of vehicle
treatment used in this study: i.p. saline for scopolamine (N5 6), i.p.
water for lactic acid (N5 6), bilateral intraplantar saline for both for-
malin and CFA (N5 5). In cases where a rat was used to test two
manipulations (e.g., scopolamine and formalin), then only the first
vehicle test was included in this analysis. Vehicle control data for
each group are shown in Figure 2.
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intensity during signal trials. Two-way ANOVA indi-
cated main effects of dose [F(5, 25)5 13,98;
P< 0.0001] and signal intensity [F(2, 10)5 40.58;
P< 0.0001], and a significant interaction [F(10, 50)5
11.58; P< 0.0001]. Scopolamine dose-dependently
reduced response accuracy during signal trials (i.e.,
percent hit), and this effect was strongest for higher
response accuracies maintained by higher signal
intensities.
Figure 2 also shows effects of all three noxious
stimuli on accuracy of performance at each signal
intensity. Two-way ANOVAs indicated main effects
of signal intensity (P< 0.0001 for all groups), but
there was not a main effect for acid concentration
[F(5, 30)5 1.344; P5 0.2729], time after formalin
[F(3, 12)5 0.6816; P5 0.5801], or time after CFA
[F(3, 24)5 0.1043; P5 0.9568]. The interaction was
also not significant between signal intensity and either
acid concentration [F(5, 30)5 1.344; P5 0.2729] or
time after CFA [F(6, 48)5 0.452; P5 0.8586]. There
was a significant interaction between signal intensity
and time after formalin [F(6, 24)5 3.780;
P5 0.0086], and Dunnett’s post hoc test indicated a
significant decrease in response accuracy at the high-
est two signal intensities 15 min after formalin
treatment.
Figure 3 shows effects of scopolamine and noxious
stimuli on response accuracy for all signal trials com-
bined and for blank trials, and one-way ANOVA results
for each trial type are shown in Table 1. Scopolamine
reduced response accuracy during both signal trials and
blank trials. Conversely, neither lactic acid nor CFA
altered accuracy during either signal trials or blank trials.
Formalin also failed to alter response accuracy during
signal trials when data were collapsed across all signal
intensities; however, formalin did reduce accuracy dur-
ing blank trials, and Dunnett’s post hoc test indicated a
significant decrease in accuracy after 15 min.
Fig. 2. The effects of (A) scopolamine, (B) lactic acid, (C) formalin, and (D) CFA on response accuracy during signal trials. Abscissae:
Change in signal light intensity in lux. Ordinates: response accuracy quantified as percent hits. Filled points show doses at which percent
hits were statistically different from vehicle as determined by two-way ANOVA followed by Dunnett’s post hoc test, P<0.05. All data show
mean6 SEM for five–nine rats.
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Effects of Scopolamine and Noxious Stimuli on
Response Latencies and Omissions
Figure 4 shows effects of scopolamine and nox-
ious stimuli on measures of response latency and
omissions, and one-way ANOVA results for each trial
type are shown in Table 1. Both scopolamine and
lactic acid dose-dependently increased response
latencies and omissions during both signal and blank
trials. Formalin also increased mean response laten-
cies and omissions after 15 min, but this effect was
significant only during blank trials, and formalin had
no effect after 3 or 7 days. CFA had no effect at any
time on either response latencies or omissions during
either signal or blank trials.
TABLE 1. One-way ANOVA Results for Data Shown in Figures 3 and 4
Scopolamine Lactic acid Formalin CFA
% Correct
Signal F(5, 25)5 13.85 F(5, 30)5 1.795 F(3, 12)5 0.6961 F(3, 24)5 0.1127
P<0.0001 P5 0.1440 P50.5721 P5 0.9518
Blank F(5, 25)5 5.027 F(5, 30)5 2.129 F(3, 12)5 5.110 F(3, 24)5 0.5480
P5 0.0025 P5 0.0892 P50.0166 P5 0.6543
Latency
Signal F(5, 25)5 12.63 F(5, 30)5 5.658 F(3, 12)5 2.285 F(3, 24)5 2.121
P<0.0001 P5 0.0009 P50.1310 P5 0.1241
Blank F(5, 25)5 12.53 F(5, 30)5 5.671 F(3, 12)5 8.995 F(3, 24)5 2.015
P<0.0001 P5 0.0009 P50.0021 P5 0.1387
Omissions
Signal F(5, 25)5 11.28 F(5, 30)5 28.94 F(3, 12)5 2.686 F(3, 24)5 0.5348
P<0.0001 P<0.0001 P50.0936 P5 0.6629
Blank F(5, 25)5 10.20 F(5, 30)5 48.28 F(3, 12)5 4.469 F(3, 24)5 1.706
P<0.0001 P<0.0001 P50.0251 P5 0.1925
Fig. 3. The effects of (A) scopolamine, (B) lactic acid, (C) formalin, and (D) CFA on response accuracy for signal and blank trials. Abscissae:
dose, concentration or pretreatment time of the compounds. Ordinates: response accuracy quantified as % correct across all signal trials or
all blank trials. Filled points show doses, concentrations or times at which % correct were statistically different from vehicle as determined
by one-way ANOVA followed by the Dunnett’s post hoc test, P<0.05. All data show mean6 SEM for five–nine rats.
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Paw Swelling and Mechanical Allodynia After
Formalin and CFA
Figure 5 shows that both CFA and formalin
treatments produced significant paw swelling and
mechanical allodynia 7 days after treatment.
DISCUSSION
Effects of Signal Intensity and Scopolamine
Treatment
The results agree with previous reports that
response accuracy in VSDT procedures is dependent
Fig. 4. The effects of (A, E) scopolamine, (B, F) lactic acid, (C, G) formalin, and (D, H) CFA on response latencies (upper panels) and omis-
sions (lower panels). Abscissae: dose, concentration or pretreatment time of the compounds. Ordinates: response latency (s, panels A–D) or
number of omissions (panels E–H). Filled points show doses, concentrations or times at which response latency or number of omissions
were statistically different from vehicle as determined by one-way ANOVA followed by the Dunnett’s post hoc test, P<0.05. All data show
mean6 SEM for five–nine rats.
Fig. 5. The effects of (A, C) formalin and (B, D) CFA on paw swelling and mechanical sensitivity. Abscissae: time before (baseline; BL) or
seven days after formalin or CFA treatment. Ordinates: paw width in mm (A, B) or paw withdrawal threshold in log grams (C, D). Asterisks
indicate that both formalin and CFA produced paw swelling [t(4)5 45.09, P<0.0001 and t(8)5 8.632, P<0.0001, respectively] and
mechanical allodynia [t(4)5 4.785 P5 0.0087 and t(8)5 3.933, P 0.0043, respectively] as assessed seven days after formalin or CFA treat-
ment. All data show mean6 SEM for five–nine rats.
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on signal intensity and impaired by scopolamine pre-
treatment [Bushnell et al., 1997; Rezvani et al.,
2009]. For example, in this study, scopolamine dis-
played similar potencies to reduce accuracy and
increase response latency during both signal and
blank trials, and it had threefold weaker potency to
increase response omissions. An identical profile of
scopolamine effects was reported by Bushnell et al.
[1997] in a VSDT procedure using slightly different
parameters for background and signal light inten-
sities. Scopolamine also impaired accuracy of per-
formance in other assays of attention in rodents,
including a five-choice serial reaction time task [Mis-
hima et al., 2002], and it has also been found to
impair measures of attention in human tests [Ellis
et al., 2006]. These findings confirm the sensitivity of
VSDT performance in this study to an established
positive control, and these scopolamine effects also
provide a context for evaluating effects of noxious
stimuli.
Effects of Noxious Stimuli
Two of the three noxious stimuli tested in this
study also altered VSDT performance. Each noxious
stimulus will be discussed in turn. First, i.p. lactic
acid administration increased both response latencies
and omissions in this study, but unlike scopolamine,
i.p. acid failed to significantly alter response accuracy
during either signal or blank trials. Similar concentra-
tions of i.p. acid in rats have also been reported to
depress operant responding for electrical brain stimu-
lation in an ICSS procedure and to stimulate a
stretching response [Pereira Do Carmo et al., 2009].
Moreover, both acid-induced depression of ICSS and
stimulation of stretching appear to be related to pain,
because both effects are blocked by clinically effec-
tive analgesics including the mu opioid agonist mor-
phine and the nonsteroidal anti-inflammatory drug
ketoprofen [Pereira Do Carmo et al., 2009; Negus,
2013; Rosenberg et al., 2013]. Overall, these results
suggest that pain-like effects produced by i.p. acid
administration in rats are sufficient to produce a non-
selective decrease in operant behavior but not to pro-
duce a disruption in response-accuracy measures of
attention in the VSDT procedure.
Of the three noxious stimuli tested here, intra-
plantar formalin produced a transient disruption of
VSDT performance that most closely resembled the
effects of scopolamine. Thus, when tested 15 min
after administration, intraplantar formalin produced a
small but significant decrease in response accuracy
during both signal and blank trials as well as a signifi-
cant increase in response latency during blank trials.
However, four caveats warrant mention. First, the
effects of formalin on response accuracy were rela-
tively small insofar as their magnitude was less than
or equal to the magnitude of effects produced by the
intermediate dose of 0.1 mg/kg scopolamine. In par-
ticular, during signal trials, formalin-induced disrup-
tion was significant only when evaluated at the
highest two signal intensities (Fig. 2), and this effect
did not achieve statistical significance when collapsed
across all signal intensities (Fig. 3). Second, in con-
trast to the effects of the intermediate scopolamine
dose, the formalin-induced decrease in accuracy was
accompanied by a significant increase in omissions
during blank trials. Third, the formalin effects were
transient, and were not evident 3 or 7 days after for-
malin administration. This corresponds to the period
of the “first and second phases” of the formalin
response (1–2 h after formalin administration) during
which rats display vigorous paw flinching and licking
responses [Tjølsen et al., 1992; Fu et al., 2001;
Abbott et al., 2002]. However, disruptions in VSDT
performance were not evident at later times when
paw edema, mechanical allodynia, and depression of
ICSS are present [this study; Fu et al., 2001; Grace
et al., 2014]. Finally, the present results agree with a
previous report that intraplantar formalin disrupted
performance in a five-choice serial reaction time task
in rats when testing occurred immediately after for-
malin injection [Boyette-Davis et al., 2008]. However,
in that study, formalin increased omissions but did
not affect either response accuracy or response
latency. Taken together, these results suggest that
intraplantar formalin is sufficient to produce a tran-
sient and scopolamine-like disruption in performance,
but the more sustained manifestations of pain-like
behavior produced by formalin do not produce sus-
tained disruption of any measure of VSDT
performance.
Lastly, intraplantar CFA failed to alter any mea-
sure of VSDT performance. Again, this lack of effect
cannot be attributed to inadequate CFA dosing,
because this CFA treatment did produce sustained
paw edema and mechanical allodynia, and similar
CFA treatments have also been shown to produce
transient decreases in ICSS and more sustained
decreases in wheel running in rats [this study; Grace
et al., 2014; Leitl et al., 2014]. These results with
intraplantar CFA differ from those in a previous
study that found both decreased accuracy and
increased omissions for 10 days after intra-articular
administration of CFA in rats responding under a
five-choice serial reaction time task [Pais-Vieira et al.,
2009]. This difference may reflect greater sensitivity
of the five-choice serial reaction time task than the
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VSDT to sustained pain, greater intensity of pain
after intra-articular than intraplantar CFA, or other
procedural differences (e.g., strain of rat studied:
Sprague-Dawley vs. Lister hooded). However, CFA
effects in that study were not blocked by the clini-
cally effective nonsteroidal anti-inflammatory drug
carprofen that did block mechanical allodynia, sug-
gesting that effects of CFA on performance may not
have been related to pain. Results of this study do
not provide evidence for a CFA-induced disruption
of attention.
CONCLUSIONS
In this study, both i.p. lactic acid and bilateral
intraplantar formalin functioned as noxious stimuli
that acutely disrupted performance in a VSDT that
has been used to assess modulators of attention in
rats. These results may be related to clinical observa-
tions of pain-related disruption of attention in
humans; however, the profiles of effects produced by
i.p. acid and intraplantar formalin were transient and
occurred during the time of maximal nociceptor acti-
vation and maximal stimulation of pain-related behav-
iors (i.e., the stretching response after i.p. acid or
paw flinching/licking responses after i.pl. formalin).
Notably, disruptions in VSDT performance were not
evident at later times after formalin treatment, or at
any time after i.pl. CFA treatment, despite the pres-
ence of both paw edema and mechanical hypersensi-
tivity. As such, these results suggest that relatively
strong activation of nociceptive pathways is required
to disrupt performance in this version of the VSDT.
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